Nobilis Provides Update on Delay in Filing of Unaudited Interim Financial Statements

Nobilis Health Corp. (NYSE MKT:

) previously announced that due to its new auditor having not completed their quarterly review procedures, it would not be in a position, by the filing deadline, to file its unaudited interim financial statements for the three and nine months ended September 30, 2015 (the "Financial Statements") and the related management's discussion and analysis ("MD&A") and related CEO and CFO certificates. It remains uncertain as to when the Company will be able to finalize its Financial Statements and related disclosures.As previously announced, the Company continues to work with its auditor to resolve certain accounting issues that are delaying the release of the Financial Statements and the MD&A. In addition to the non-cash opening balance sheet valuations related to business combinations as previously disclosed, these issues include: (1) accounting for warrants and options issued in the Company's private placements in 2013, 2014 and 2015 and options granted to non-employees; (2) reclassification of contingently redeemable noncontrolling interests to temporary equity, (3) share-based compensation matters and (4) calculations of fully diluted shares outstanding for application of the treasury stock method.The Company has made and the